BioWorld MedTech

July 17, 2018

View Archived Issues

Stryker's flow diverter receives FDA thumbs up

Stryker Corp., of Kalamazoo, Mich., won FDA approval for the Surpass Streamline flow diverter to treat unruptured large and giant wide neck intracranial aneurysms. It is the second flow diverting stent to gain a green light in the U.S. Read More

FDA inks only 11 warnings to device makers to date in 2018

Read More

Researchers develop new imaging approach to detect cardiac stress, inflammation

Read More

Safe Orthopaedics raises $8.12M to boost its MIS spinal fracture treatment offerings

Read More

Prenatal gene therapy corrects fatal brain disease

Read More

Other news to note

Read More

Financings

Read More

Appointments and advancements

Read More

Product briefs

Read More

BioWorld MedTech's Cardiology Extra

Read More